Sarah Helton
🏛️ Revolving DoorFormer Government Positions:
Intern Congressman Sensenbrenner, 2006
Intern, House of Representatives
Intern, US House of Representatives
Intern, House of Representatives; Intern, Senate
Intern, Rep. Jim Sensenbrenner
🤖
AI Overview
Sarah Helton has appeared in 675 federal lobbying filings at Michael Best Strategies LLC, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 27 policy areas.
675
Total Filings
1
Firms
50
Clients
27
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 35 | 14 |
| 2019 | 82 | 23 |
| 2020 | 98 | 36 |
| 2021 | 84 | 30 |
| 2022 | 97 | 23 |
| 2023 | 93 | 24 |
| 2024 | 88 | 18 |
| 2025 | 98 | 24 |
Firms
Michael Best Strategies LLC675 filings
Top Clients
Usana Health Sciences INC.52 filings
Hyster-yale Materials Handling, INC.34 filings
One Hope United34 filings
Primex Family of Companies24 filings
Dober Chemical Corp.24 filings
Channel Products, INC.23 filings
Nuvera Fuel Cells19 filings
Snp INC.17 filings
Haribo Group of America16 filings
Trillium Cng12 filings
Gsm-walker Products12 filings
The Hillman Group12 filings
Renaissance Learning, INC.12 filings
Ecm Industries LLC11 filings
Amneal Pharmaceutical11 filings
Trc Companies INC.10 filings
Nacco Industries, INC.9 filings
Musco Family Olive Co.9 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The 22,000% ROI
When lobbying spending yields outsized returns.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.